Researchers at Stanford Medicine have built human lung organoids, lab-grown miniature lung tissue, with a built-in immune system, creating a model in which tissue-resident immune cells can be studied doing their jobs where they actually live. The work, published in Nature, centres on resident T cells, the immune cells that take up long-term residence in the lung rather than circulating through the blood.
Early findings from the model suggest those resident T cells may be much more persistent than previously thought, according to the study’s senior author. That persistence matters because resident cells, not visitors from the bloodstream, are the first immune presence a respiratory virus meets, and their behaviour in the first hours of infection can shape everything that follows.
Until now, studying that first encounter meant animal models or inference from blood samples, neither of which shows human lung tissue and its own immune residents interacting directly. An organoid that contains both lets researchers watch antiviral responses in the tissue itself, and test what changes them.
The team sees the widest implications in vaccination. If resident immunity can be deliberately established in the lung, local vaccination, delivered where infection begins rather than into an arm, could complement or eventually supplement traditional systemic vaccines. The same models could extend to chronic obstructive pulmonary disease, asthma and bacterial infections, the authors say, anywhere the lung’s own immune residents are part of the story.
Organoids have been growing more complete for a decade, adding blood vessels, nerves and now resident immunity, each addition making the model less a sculpture of an organ and more a working miniature of one. The closer the model gets, the more questions it can answer before a treatment ever reaches a patient.
Stanford’s team is explicit about what the model is not: an organoid has no circulation, no nerves, no cough, and no patient. But as a place to ask the first hundred questions about resident immunity, which treatments coax it, which viruses evade it, it replaces inference with observation. Drug and vaccine candidates that fail in such models fail cheaply and privately, and the ones that reach human trials arrive with evidence gathered in human tissue rather than in mice.
US News Zone will continue to follow this research as further findings are published.
Related reading: A Spacecraft Photographs a Complete Auroral Oval From Above the Pole · Crops Face Many Stresses at Once, and Science Should Study Them That Way · Ancient Bat Specimens Help Scientists Read a Rare Species' Present
